Welcome to our dedicated page for U S PHYSICAL THERAPY /NV SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on U S PHYSICAL THERAPY /NV's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into U S PHYSICAL THERAPY /NV's regulatory disclosures and financial reporting.
U.S. Physical Therapy, Inc. has acquired a twelve-clinic physical therapy practice, effective July 1, 2026, taking a 67% equity interest while the current owners retain 33%.
The acquired practice generates about 112,000 annual patient visits and $12 million in annual revenue. This deal expands USPH’s footprint from 44 to 45 states, supporting its national network of 795 outpatient physical therapy clinics and its industrial injury prevention services business.
U.S. Physical Therapy interim CFO Jason Travis surrendered 40 shares of common stock at $62.24 per share to satisfy tax withholding obligations when restricted stock vested.
After this tax-withholding disposition, he directly holds 3,893 shares, including 3,596 restricted shares scheduled to vest over multiple dates through 2030, contingent on continued service.
U.S. Physical Therapy COO Graham D. Reeve reported a routine share disposition related to taxes. On May 20, he surrendered 762 shares of Common Stock at $62.24 per share to the company to satisfy tax withholding obligations upon vesting of equity awards. After this transaction, he directly holds 29,316 shares, including 19,436 restricted shares that are scheduled to vest in tranches from August 20, 2026 through March 6, 2030, contingent on continued employment.
U.S. Physical Therapy director Peter Francis Minan reported buying company stock in the open market. He purchased 492 shares of common stock on June 8, 2026 at $63.14 per share and 288 shares on June 9, 2026 at $61.50 per share, totaling 780 shares.
After these trades, he directly holds 3,211 common shares. Footnotes state this includes 2,306 shares granted as restricted stock, with restrictions scheduled to lapse on August 20, 2026, November 20, 2026, and March 6, 2027 if he remains a director on those dates.
Swanson Regg E. reported acquisition or exercise transactions in this Form 4 filing.
U.S. Physical Therapy director Regg E. Swanson reported a stock award and updated holdings. He received a grant of 2,306 shares of common stock at a reported price of $0.00 per share as a compensation-related award.
The filing notes this corrects a prior report that had used $61.61 as the transaction price. Following the award, Swanson holds 15,492 shares directly and 7,596 shares indirectly through the Regg E. Swanson Revocable Trust, where he is beneficiary and trustee.
The 2,306 restricted shares vest in tranches: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if he remains a director on those dates.
Motsenbocker Anne reported acquisition or exercise transactions in this Form 4 filing.
U.S. Physical Therapy director Anne Motsenbocker received an equity grant of 2,306 shares of common stock on May 19, 2026. The shares were granted at $0.00 as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan, bringing her direct holdings to 9,812 shares.
The restrictions lapse in stages if she continues as a director: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027.
Minan Peter Francis reported acquisition or exercise transactions in this Form 4 filing.
U.S. Physical Therapy director Peter Francis Minan received a grant of 2,306 shares of common stock as a stock award, with a corrected transaction price of $0.00 per share. This award was issued as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan.
Following the grant, he holds 2,431 shares directly. The restrictions on these 2,306 shares lapse in stages: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, provided he is a director on those dates.
Harris Bernard A Jr reported acquisition or exercise transactions in this Form 4 filing.
U S Physical Therapy director Bernard A. Harris Jr. received a grant of 2,306 shares of common stock as a restricted stock award. The grant was made at a reported transaction price of $0.00 per share and increased his direct holdings to 20,914 shares.
These 2,306 restricted shares vest in stages under the company’s Amended and Restated 2003 Stock Incentive Plan: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if he remains a director on those dates.
Gilmartin Kathleen A reported acquisition or exercise transactions in this Form 4 filing.
U.S. Physical Therapy director Kathleen A. Gilmartin received an award of 2,306 shares of Common Stock as a stock grant. The award was granted at a price of $0.00 per share as compensation, not an open-market purchase or sale.
After this grant, she holds 27,092 shares directly. The grant is in the form of restricted stock under the Company Amended and Restated 2003 Stock Incentive Plan, with portions scheduled to vest on specified future dates if she continues serving as a director.
Motsenbocker Anne reported acquisition or exercise transactions in this Form 4 filing.
U S Physical Therapy director Anne Motsenbocker received a grant of 2,306 shares of common stock at $61.61 per share as equity compensation. This award increased her direct holdings to 9,812 shares of the company’s stock.
The 2,306 granted shares are restricted stock. According to the terms, restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if she remains a director on those dates.